US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ETHZilla Corporation

4.29

+1.9281.01%

Post-market: 3.92-0.3700-8.62%19:59 EDT

Volume:40.35M

Turnover:176.53M

Market Cap:87.14M

PE:-0.08

High:5.55

Open:2.99

Low:2.76

Close:2.37

52wk High:174.60

52wk Low:1.76

Shares:20.31M

Float Shares:15.13M

Volume Ratio:41.61

T/O Rate:266.62%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-55.1771

EPS(LYR):-55.1771

ROE:-356.72%

ROA:-91.46%

PB:0.36

PE(LYR):-0.08

Loading ...

Overview Company News Filings

Company Profile

Company Name:

ETHZilla Corporation

Exchange:

NASDAQ

Establishment Date:

- -

Employees:

4

Office Location:

2875 South Ocean Blvd,Suite 200,Palm Beach,Florida,United States

Website:

http://forum-markets.com;ir.forum-markets.com

Zip Code:

33480

Phone:

Fax:

- -

Introduction:

180 Life Sciences Corp., a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. The company product development platforms includes fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which has completed Phase IIb clinical trials that focuses on fibrosis and anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are synthetic pharmaceutical grade molecules close or distant analogs of non-psychoactive cannabinoids, such as CBD for the treatment of inflammatory diseases and pain; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. 180 Life Sciences Corp. is headquartered in Palo Alto, California.

Directors

Name

Position

McAndrew Rudisill

CEO and Executive Chairman

Andrew Suckling

Independent Director

Angela Dalton

Independent Director

Crystal Heter

Independent Director

Jason New

Independent Director

Michael Edwards

Independent Director

Ryan Smith

Lead Independent Director

Shareholders

Name

Position

John Saunders

CFO, Vice President of Finance and Secretary

McAndrew Rudisill

CEO and Executive Chairman

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/FRMM/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FRMM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FRMM\",,,,,undefined,":{"symbol":"FRMM","market":"US","secType":"STK","nameCN":"ETHZilla Corporation","latestPrice":4.29,"timestamp":1776456000000,"preClose":2.37,"halted":0,"volume":40349213,"hourTrading":{"tag":"盘后","latestPrice":3.92,"preClose":4.29,"latestTime":"19:59 EDT","volume":3490147,"amount":14287150.0167,"timestamp":1776470399721,"change":-0.37,"changeRate":-0.086247,"amplitude":0.212121},"delay":0,"changeRate":0.810126582278481,"floatShares":15133322,"shares":20313111,"eps":-55.177097,"marketStatus":"Market Closed","change":1.92,"latestTime":"04-17 16:00:00 EDT","open":2.99,"high":5.55,"low":2.76,"amount":176531692.5042119,"amplitude":1.177215,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-55.177097,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1776672000000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":2.37,"preHourTrading":{"tag":"盘前","latestPrice":2.98,"preClose":2.37,"latestTime":"09:29 EDT","volume":140896,"amount":386188.468512,"timestamp":1776432596310,"change":0.61,"changeRate":0.257384,"amplitude":0.307215},"postHourTrading":{"tag":"盘后","latestPrice":3.92,"preClose":4.29,"latestTime":"19:59 EDT","volume":3490147,"amount":14287150.0167,"timestamp":1776470399721,"change":-0.37,"changeRate":-0.086247,"amplitude":0.212121},"volumeRatio":41.61493907273363,"impliedVol":2.4812,"impliedVolPercentile":0.5588},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FRMM\",,,,,undefined,":{"symbol":"FRMM","floatShares":15133322,"roa":"-91.46%","roe":"-356.72%","lyrEps":-55.177097,"volumeRatio":41.61493907273363,"shares":20313111,"dividePrice":0,"high":5.55,"amplitude":1.177215,"preClose":2.37,"low":2.76,"week52Low":1.76,"pbRate":"0.36","psRate":"13.31","week52High":174.6,"institutionHeld":0,"latestPrice":4.29,"eps":-55.177097,"divideRate":0,"volume":40349213,"delay":0,"ttmEps":-55.177097,"open":2.99,"prevYearClose":4.9,"prevWeekClose":1.96,"prevMonthClose":2.89,"prevQuarterClose":2.89,"fiveDayClose":1.96,"twentyDayClose":2.81,"sixtyDayClose":5.06},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FRMM\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-31","symbol":"FRMM","fiscalQuarterEnding":"2025/12","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1774929600000,"reportTimeType":"pre","actualEps":-12.14},{"market":"US","date":"2025-11-14","symbol":"FRMM","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"pre","actualEps":-16.8},{"market":"US","date":"2025-10-20","symbol":"FRMM","defaultRemindTime":1760967000000,"type":"split","dateTimestamp":1760932800000,"forFactor":10,"toFactor":1,"ratio":10}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FRMM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FRMM\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1775620800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/FRMM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"FRMM","date":"2026-04-17","current":-0.07775,"percent":0.75,"low":-0.292221,"twenty":-0.253486,"median":-0.244081,"eighty":-0.096489,"high":-0.080708,"avg":-0.203351,"sd":0.071539,"marketCap":48142073},"quantilePoints":[{"date":"2026-03-06","current":-0.253371,"twenty":-0.283607,"median":-0.268574,"eighty":-0.256918,"marketCap":57036693},{"date":"2026-03-13","current":-0.251682,"twenty":-0.266715,"median":-0.254216,"eighty":-0.249993,"marketCap":56656448},{"date":"2026-03-20","current":-0.237324,"twenty":-0.257256,"median":-0.252526,"eighty":-0.244081,"marketCap":53424369},{"date":"2026-03-27","current":-0.240702,"twenty":-0.255398,"median":-0.251682,"eighty":-0.242729,"marketCap":54184858},{"date":"2026-04-02","current":-0.253563,"twenty":-0.254722,"median":-0.248304,"eighty":-0.238675,"marketCap":57079841},{"date":"2026-04-10","current":-0.09198,"twenty":-0.253955,"median":-0.245347,"eighty":-0.229047,"marketCap":41438746},{"date":"2026-04-17","current":-0.106859,"twenty":-0.253486,"median":-0.244081,"eighty":-0.096489,"marketCap":48142073}],"updateTime":1776538771923},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":587644367,"employeeNum":4,"address":"2875 South Ocean Blvd,Suite 200,Palm Beach,Florida,United States","zipCode":"33480","officePhone":"650 507 0669","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://forum-markets.com;ir.forum-markets.com","stockEarnings":[{"period":"1week","weight":1.1888},{"period":"1month","weight":0.5267},{"period":"3month","weight":-0.2326},{"period":"6month","weight":-0.7446},{"period":"1year","weight":-0.5225},{"period":"ytd","weight":-0.1245}],"compareEarnings":[{"period":"1week","weight":0.0452},{"period":"1month","weight":0.0736},{"period":"3month","weight":0.0267},{"period":"6month","weight":0.0689},{"period":"1year","weight":0.349},{"period":"ytd","weight":0.0414}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"180 Life Sciences Corp., a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. The company product development platforms includes fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which has completed Phase IIb clinical trials that focuses on fibrosis and anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are synthetic pharmaceutical grade molecules close or distant analogs of non-psychoactive cannabinoids, such as CBD for the treatment of inflammatory diseases and pain; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. 180 Life Sciences Corp. is headquartered in Palo Alto, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.444444,"avgChangeRate":-0.042356},{"month":2,"riseRate":0.444444,"avgChangeRate":-0.019869},{"month":3,"riseRate":0.222222,"avgChangeRate":-0.091242},{"month":4,"riseRate":0.444444,"avgChangeRate":0.035552},{"month":5,"riseRate":0.5,"avgChangeRate":-0.054077},{"month":6,"riseRate":0.75,"avgChangeRate":-0.042052},{"month":7,"riseRate":0.666667,"avgChangeRate":0.295972},{"month":8,"riseRate":0,"avgChangeRate":-0.113877},{"month":9,"riseRate":0.444444,"avgChangeRate":-0.065182},{"month":10,"riseRate":0.222222,"avgChangeRate":0.056496},{"month":11,"riseRate":0.222222,"avgChangeRate":-0.206764},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.21111}],"exchange":"NASDAQ","name":"ETHZilla Corporation","nameEN":"ETHZilla Corporation"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"FRMM\",market:\"US\",,,undefined,":{"directors":[{"name":"McAndrew Rudisill","position":"CEO and Executive Chairman"},{"name":"Andrew Suckling","position":"Independent Director"},{"name":"Angela Dalton","position":"Independent Director"},{"name":"Crystal Heter","position":"Independent Director"},{"name":"Jason New","position":"Independent Director"},{"name":"Michael Edwards","position":"Independent Director"},{"name":"Ryan Smith","position":"Lead Independent Director"}],"executives":[{"name":"John Saunders","position":"CFO, Vice President of Finance and Secretary"},{"name":"McAndrew Rudisill","position":"CEO and Executive Chairman"}]}}}